1
|
Ng et al. (1997)
|
58/M
|
Symmetric weakness, hyporeflexia, asthma
|
Eosinophilia, raised ESR, P-ANCA + ve
|
Mixed demyelinating polyneuropathy, multifocal absent F waves
|
Lung infiltrates
|
Steroids, cyclophosphamide, plasma exchange
|
Expired
|
2
|
Kevent et al. (1998)
|
57/M
|
Symmetric weakness, hyporeflexia
|
Raised ESR, P-ANCA + ve
|
Mixed demyelinating polyneuropathy, multifocal absent F waves
|
Nephritis
|
Steroids
|
Improved
|
3
|
Riva et al. (2008)
|
51/F
|
Asthma, nasal polyposis, symmetric weakness, hyporeflexia
|
Eosinophilia, raised ESR, P-ANCA -ve
|
Motor asymmetric axonal polyneuropathy, multifocal absent F waves
| |
IVIg, steroids
|
Improved
|
4
|
Djukic et al. (2008)
|
74/M
|
Asthma, symmetric weakness, hyporeflexia
|
Eosinophilia
|
Mixed demyelinating polyneuropathy, multifocal absent F waves
| |
Steroids, cyclophosphamide
|
Improved
|
5
|
Lemarroy et al. (2015)
|
36/F
|
Asthma, pansinusitis, purpura, symmetric weakness, hyporeflexia
|
Eosinophilia, raised ESR, P-ANCA + ve
|
Motor asymmetric axonal polyneuropathy
| |
Steroids, cyclophosphamide
|
Improved
|
6
|
Bortolani et al. (2016)
|
68/F
|
Asthma, symmetric weakness, areflexia
|
Eosinophilia, P-ANCA + ve
|
Motor axonal polyneuropathy
| |
Steroids
|
Improved
|
7
|
Yadav et al. (2017)
|
57/F
|
Asthma, symmetric weakness, hyporeflexia
|
Eosinophilia, proteinuria, P-ANCA + ve
|
Severe axonal and demyelinating polyneuropathy
|
Nephritis
|
Steroids, cyclophosphamide
|
Improved
|
8
|
Kim et al. (2018)
|
51/F
|
Asthma, asymmetric weakness, hyporeflexia, purpura
|
Eosinophilia, maxillary sinusitis, P-ANCA + ve
|
Sensory, motor, axonal, polyneuropathy
| |
Steroids
|
Improved
|